HSCS

HeartSciences Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website eartsciences.com
Employees(FY) 12
ISIN US42254E3027

Performance

+1.52%

-26.65%

-25.42%

-52.58%

-84.39%

YTD

-88.69%

Profile

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Advanced Technical Analysis

Technical Analysis of HSCS 2024-11-22

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward pressure, while the Oscillators Score of 56 suggests a neutral stance, and the Technical Score of 33 reinforces the bearish outlook. This combination implies that while there may be some oscillatory movements, the prevailing tre...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of HSCS

Stock Rank

Recent News & Updates

2024-11-12 20:00
HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement(Globenewswire)
2024-10-14 04:15
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit(Globenewswire)
2024-09-12 04:15
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results(Globenewswire)
2024-09-11 21:00
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission(Globenewswire)
2024-07-29 04:05
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results(Globenewswire)
2024-07-25 21:00
Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista wavECG Potential to Improve Cardiovascular Pathway Efficiency(Globenewswire)
2024-07-24 20:30
HeartSciences Selected to Demonstrate MyoVista wavECG at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare(Globenewswire)
2024-07-10 21:00
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction(Globenewswire)
2024-06-04 04:15
HeartSciences Regains Compliance with Nasdaq Listing Requirements(Globenewswire)
2024-05-19 21:00
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio(Globenewswire)
2024-05-12 19:23
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday(Investorplace)
2024-04-23 21:00
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG(Globenewswire)
2024-04-02 04:15
HeartSciences to Present at the LD Micro Invitational XIV Conference(Globenewswire)
2024-03-25 21:00
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients(Globenewswire)
2024-03-14 09:54
HSCS Stock Earnings: Heart Test Laboratories Beats EPS for Q3 2024(Investorplace)
2024-03-14 04:15
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results(Globenewswire)
2024-03-11 21:00
HeartSciences' Announces Peer-Reviewed Publication Evaluating Use of MyoVista Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes(Globenewswire)
2024-03-05 20:20
Why Is Heart Test Laboratories (HSCS) Stock Down 21% Today?(Investorplace)
2024-03-05 20:00
HeartSciences Announces Canada Patent Grant Covering MyoVista Wavelet Technology(Globenewswire)
2024-02-25 20:00
HeartSciences Adds Key Advisor to its Scientific Advisory Board(Globenewswire)
2024-02-11 20:00
HeartSciences Expands its Scientific Advisory Board(Globenewswire)
2024-01-31 20:00
HeartSciences Appoints New Scientific Advisory Board Member(Globenewswire)
2024-01-17 19:00
HeartSciences Announces Results and Adjournment of Annual Shareholder Meeting(Globenewswire)
2024-01-03 03:15
HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder Meeting(Globenewswire)
2023-12-17 22:52
HSCS Stock Earnings: Heart Test Laboratories Misses EPS for Q2 2024(Investorplace)
2023-12-14 03:15
HeartSciences Reports Second Quarter Fiscal 2024 Financial Results(Globenewswire)
2023-12-04 19:00
HeartSciences Receives FDA Confirmation for 510(k) Clearance Pathway(Globenewswire)
2023-11-19 19:00
HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms(Globenewswire)
2023-11-14 19:07
Why Is Heart Test Laboratories (HSCS) Stock Up 43% Today?(Investorplace)
2023-11-12 19:45
HeartSciences' MyoVista wavECGTM Selected for Heart Screening of Irish Garda National Police Officers(Globenewswire)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.